🏛️ Verified NIH Record • Updated 2025-10-08

The Cancer of the Pancreas Screening-5 CAPS5)Study (NCT02000089)

🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Johns Hopkins University

🩺 Plain-English Summary (8th-Grade Level)

Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (7 items).

Location: Yale University — New Haven, Connecticut

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Medical comorbidities or coagulopathy that contraindicate endoscopy
  • Prior surgery that prevent optimal endoscopic ultrasound such as partial or complete gastrectomy with Bilroth or Roux-en-Y anastomosis
  • Stricture or obstruction in the upper GI tract that does not allow passage of the echoendoscope
  • Poor performance status
  • Inability to provide informed consent
  • Pregnancy.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (9 Sites)

  • Yale University — New Haven, Connecticut
  • Johns Hopkins Hospital — Baltimore, Maryland
  • Dana Farber Cancer Center, Harvard University — Boston, Massachusetts
  • University of Michigan — Ann Arbor, Michigan
  • NYU Langone Medical Center — New York, New York
  • Columbia University Medical Center — New York, New York
  • Case Comprehensive Cancer Center, Case Western Medical Reserve — Cleveland, Ohio
  • University of Pennsylvania — Philadelphia, Pennsylvania
  • University of Pittsburgh — Pittsburgh, Pennsylvania

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
🏛️ View Official NIH Record ↗